XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 26,742 $ 38,704
Restricted cash 2,500  
Investment in equity securities, at fair value 6,309 9,868
Accounts receivable, net of $0 allowance for doubtful accounts 12,560 9,803
Inventories 5,773 1,907
Prepaid expenses and other 1,728 1,688
Total current assets 55,612 61,970
Property, plant and equipment, net 13,867 12,712
Intangible assets, net 10,049 12,203
Long-term investments 39,780 40,128
Right of use assets 7,666 9,107
Other assets 932 2,178
Total assets 127,906 138,298
Current liabilities:    
Accounts payable 3,098 4,789
Bank borrowings 3,000  
Accrued and other current liabilities 23,651 8,397
Total current liabilities 29,749 13,186
Deferred income 2,488 2,828
Other liabilities 12,455 14,325
Total liabilities 44,692 30,339
Commitments and contingencies
Redeemable noncontrolling interest, at redemption value 21,503 23,457
Stockholders' equity:    
Preferred stock, $1.00 par value: 5,000,000 shares authorized and 0 shares issued and outstanding 0 0
Common stock, $0.01 par value: 250,000,000 shares authorized at June 30, 2022 and December 31, 2021 13,733,459 shares and 13,987,578 shares issued at June 30, 2022 and December 31, 2021, respectively; 13,606,130 shares and 13,979,624 shares outstanding at June 30, 2022 and December 31, 2021, respectively 1,373 1,399
Additional paid-in capital 696,213 694,826
Treasury stock, at cost: 127,329 shares and 7,954 shares held at June 30, 2022 and December 31, 2021 (9,068) (8,034)
Accumulated other comprehensive income (1,951) 1,954
Accumulated deficit (624,856) (605,643)
Total stockholders' equity 61,711 84,502
Total liabilities, redeemable noncontrolling interest and stockholders' equity $ 127,906 $ 138,298